Novartis funds innovative medical education programs to advance diagnosis, management, and multidisciplinary care of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) for healthcare professionals.
Funder: Novartis
Due Dates: August 14, 2026
Funding Amounts: Up to $350,000 total available; multiple awards possible; typical project period is up to 1 year.
Summary: Supports independent, innovative medical education programs to advance diagnosis, management, and multidisciplinary care of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Key Information: Proposals must be US-focused and submitted via Novartis Grants Central Station by 5 PM EST.
The Novartis Office of Grants & Education (NOGE) invites proposals for independent, high-quality medical education programs focused on gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The goal is to provide fair-balanced, evidence-based, and current scientific information to healthcare professionals, ultimately improving patient care and outcomes for GEP-NET patients. Programs should be educational, non-promotional, and comply with ACCME, PhRMA Code, OIG, and Novartis-specific guidelines.
Priority is given to innovative continuing medical education initiatives that:
Supported formats include national society conferences, curriculum-based education (live and web-based), novel audience engagement programs, and event series with regional or national impact.